Cancer is complicated, especially with multiple diagnoses, oncologists, tests and integrative treatments, but AI can be a ...

More than 60% of patients with relapsed or refractory KMT2Ar acute leukemia responded to the menin inhibitor revumenib.

CURE partnered with SHARE Cancer Support to learn more about the importance of emotional well-being and a strong support ...

Lazcluze demonstrated significant CNS activity, regardless of T790M status, in treating intracranial and leptomeningeal ...

This trial is assessing CBX-12 as a potential treatment for ovarian cancer, with additional studies to be conducted in other ...

Among patients with Merkel cell carcinoma, using ctDNA testing may help with watching the disease for potential recurrences ...

For patients with adenocarcinoma of the esophagus and esophagogastric junction, chemoradiotherapy and chemotherapy improved ...

Call to Action: Proposed FDA Regulations Could Limit Cancer Patient Access to Life-Saving Therapies ...

I’ve recently started on chemotherapy pills instead of infusions and the bitterness reminds me to accept not only the ...

First-line Keytruda plus chemotherapy is the new standard of care for patients with advanced pleural mesothelioma after the ...

In some patients with head and neck cancer, those who require dental care after cancer treatment may face financial burdens ...

The biologics license application seeks potential approval of a Darzalex Faspro-based regimen for newly diagnosed multiple ...